Navigation Links
Novel way to fight cancer

Scientists feel that they have found a innovative way to fight deadly cancers: increase a patient's immune cells in the laboratory to recognize and fight the patient's own tumor, then inject the cells back into the body and let them go to work.//

Known as adoptive transfer, the experimental technique involves the body's T cells, which are responsible for finding and attacking foreign cells that have entered the body. In the experiment, the scientists extracted some of these cells from 15 patients suffering from the deadly form of skin cancer, melanoma, then exposed them in the laboratory to a small segment of the patient's tumor. The cells learned to recognize the tumor fragment as a foreign body and fight it. Additionally the cells also multiplied, providing enough cells to replace the patient's existing immune system, which had proven ineffective at fighting the cancer on its own.

The researchers then used chemotherapy to destroy the patient's ineffective immune system and replaced it with the T cells grown in the laboratory. In 10 of the 16 patients, the treatment resulted in at least a 62 percent shrinkage of the tumors, with no re-growth or appearance of new tumors. Some tumor disappearance was noted in four other patients. The effects lasted for four months, at which time the patient's own immune system recovered and took over its usual job of fighting infections.

The technique, say the investigators, is a major improvement over past attempts to treat cancer with immune cells. Steven A. Rosenberg, M.D., Ph.D., "In the past, only a fraction of a percent of the cells we injected were able to survive, and they would persist for only a few days." In this study, he continues, "We have been able to generate a very large number of immune cells that appear in the blood and constitute a majority of the immune system of the patient. These persist for over four months and are able to attack the tumor."


'"/>




Page: 1

Related medicine news :

1. Novel "CYCLOSPORINE CAPSULE FORMULATION" to be launched
2. Novel biopsy technique for prostate cancer
3. Novel computer model for breast cancer
4. Novel research on liver cancer
5. Novel test for bowel cancer
6. Novel Anti-Neutrophilic Effect produced by Salmeterol in mild asthma patients
7. Novel Therapy for Chronic Problem
8. Blood Sugar Kept In Control By Novel Protein
9. Novel antibiotic dressing developed for improved wound healing
10. United Kingdom Is Lagging In Novelty In The Field Of Pharmaceuticals
11. Novel drug holds promise for treatment of Rheumatoid Arthritis
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/27/2016)... Dublin, CA (PRWEB) , ... June 27, 2016 ... ... Community College District , the only authorized OSHA Training Institute Education Center headquartered ... illness by protecting their workers from extreme heat at their worksites. Employers ...
(Date:6/27/2016)... , ... June 27, 2016 , ... "FCPX editors can ... inside of Final Cut Pro X," said Christina Austin - CEO of Pixel Film ... Final Cut Pro X users can now reveal the media of their ...
(Date:6/27/2016)... ... June 27, 2016 , ... ... health professionals, announced today its affiliation with Tennessee Counseling Association. This ... the network of the Tennessee Counseling Association, adding exclusive benefits and promotional offers. ...
(Date:6/27/2016)... ... June 27, 2016 , ... ... patient payment industry today announced its strategic partnership with Connance, a healthcare ... , The two companies’ proven, proprietary technology combine to provide health systems, ...
(Date:6/27/2016)... ... June 27, 2016 , ... A revolution is underway. ... ambulance transport experience for the millions of people who require these medical transport ... taxi industry through the use of technology. Now, SmartEMS has put forth an ...
Breaking Medicine News(10 mins):
(Date:6/26/2016)... , June 26, 2016 One of Australia,s ... announced the formation of a new biotechnology company, Noxopharm Limited [ABN ... in an IPO and to list on the ASX. ... NOX66, ready to enter a Phase 1 clinical study later this ... to address one of the biggest problems facing cancer patients - ...
(Date:6/26/2016)... , June 27, 2016 Jazz Pharmaceuticals plc ... period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, ... of Celator Pharmaceuticals, Inc. ("Celator"; Nasdaq: CPXX ... (Eastern Daylight Time). As previously announced on ... a definitive merger agreement under which Jazz Pharmaceuticals has ...
(Date:6/26/2016)... , June 27, 2016  VMS Rehab Systems, ... Board will take whatever measures required to build a ... stock which is currently listed on the OTC Markets-pink ... Company Chairman and CEO, "We are seeing an anomaly ... to understand, not only by the Company, but shareholders ...
Breaking Medicine Technology: